MedPath
HSA Approval

NEUROGEN-E TABLET

SIN08875P

NEUROGEN-E TABLET

NEUROGEN-E TABLET

August 22, 1996

ZUELLIG PHARMA PTE. LTD.

ZUELLIG PHARMA PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZUELLIG PHARMA PTE. LTD.
Licence HolderZUELLIG PHARMA PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

A11JA

维生素的复方

Manufacturer Information

ZUELLIG PHARMA PTE. LTD.

UNITED LABORATORIES INC

Active Ingredients

VITAMIN E (as ALPHA TOCOPHERYL ACID SUCCINATE)

100 iu

Vitamin E

CYANOCOBALAMIN

1000 mcg

Vitamin B12

THIAMINE

300 mg

Thiamine

PYRIDOXINE

300 mg

Pyridoxine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NEUROGEN-E TABLET - HSA Approval | MedPath